Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function.
Intestinal current measurements (ICM) from rectal biopsies are a sensitive means to detect cystic fibrosis transmembrane conductance regulator (CFTR) function, but have not been optimized for multicenter use. We piloted multicenter standard operating procedures (SOPs) to detect CFTR activity by ICM...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3769519?pdf=render |
_version_ | 1819028356823252992 |
---|---|
author | John P Clancy Rhonda D Szczesniak Melissa A Ashlock Sarah E Ernst Lijuan Fan Douglas B Hornick Philip H Karp Umer Khan James Lymp Alicia J Ostmann Amir Rezayat Timothy D Starner Shajan P Sugandha Hongtao Sun Nancy Quinney Scott H Donaldson Steven M Rowe Sherif E Gabriel |
author_facet | John P Clancy Rhonda D Szczesniak Melissa A Ashlock Sarah E Ernst Lijuan Fan Douglas B Hornick Philip H Karp Umer Khan James Lymp Alicia J Ostmann Amir Rezayat Timothy D Starner Shajan P Sugandha Hongtao Sun Nancy Quinney Scott H Donaldson Steven M Rowe Sherif E Gabriel |
author_sort | John P Clancy |
collection | DOAJ |
description | Intestinal current measurements (ICM) from rectal biopsies are a sensitive means to detect cystic fibrosis transmembrane conductance regulator (CFTR) function, but have not been optimized for multicenter use. We piloted multicenter standard operating procedures (SOPs) to detect CFTR activity by ICM and examined key questions for use in clinical trials. SOPs for ICM using human rectal biopsies were developed across three centers and used to characterize ion transport from non-CF and CF subjects (two severe CFTR mutations). All data were centrally evaluated by a blinded interpreter. SOPs were then used across four centers to examine the effect of cold storage on CFTR currents and compare CFTR currents in biopsies from one subject studied simultaneously either at two sites (24 hours post-biopsy) or when biopsies were obtained by either forceps or suction. Rectal biopsies from 44 non-CF and 17 CF subjects were analyzed. Mean differences (µA/cm(2); 95% confidence intervals) between CF and non-CF were forskolin/IBMX=102.6(128.0 to 81.1), carbachol=96.3(118.7 to 73.9), forskolin/IBMX+carbachol=200.9(243.1 to 158.6), and bumetanide=-44.6 (-33.7 to -55.6) (P<0.005, CF vs non-CF for all parameters). Receiver Operating Characteristic curves indicated that each parameter discriminated CF from non-CF subjects (area under the curve of 0.94-0.98). CFTR dependent currents following 18-24 hours of cold storage for forskolin/IBMX, carbachol, and forskolin/IBMX+carbachol stimulation (n=17 non-CF subjects) were 44%, 47.5%, and 47.3%, respectively of those in fresh biopsies. CFTR-dependent currents from biopsies studied after cold storage at two sites simultaneously demonstrated moderate correlation (n=14 non-CF subjects, Pearson correlation coefficients 0.389, 0.484, and 0.533). Similar CFTR dependent currents were detected from fresh biopsies obtained by either forceps or suction (within-subject comparisons, n=22 biopsies from three non-CF subjects). Multicenter ICM is a feasible CFTR outcome measure that discriminates CF from non-CF ion transport, offers unique advantages over other CFTR bioassays, and warrants further development as a potential CFTR biomarker. |
first_indexed | 2024-12-21T05:57:04Z |
format | Article |
id | doaj.art-a825b39f5ba248d7855a452f650e4730 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-21T05:57:04Z |
publishDate | 2013-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-a825b39f5ba248d7855a452f650e47302022-12-21T19:13:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7390510.1371/journal.pone.0073905Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function.John P ClancyRhonda D SzczesniakMelissa A AshlockSarah E ErnstLijuan FanDouglas B HornickPhilip H KarpUmer KhanJames LympAlicia J OstmannAmir RezayatTimothy D StarnerShajan P SugandhaHongtao SunNancy QuinneyScott H DonaldsonSteven M RoweSherif E GabrielIntestinal current measurements (ICM) from rectal biopsies are a sensitive means to detect cystic fibrosis transmembrane conductance regulator (CFTR) function, but have not been optimized for multicenter use. We piloted multicenter standard operating procedures (SOPs) to detect CFTR activity by ICM and examined key questions for use in clinical trials. SOPs for ICM using human rectal biopsies were developed across three centers and used to characterize ion transport from non-CF and CF subjects (two severe CFTR mutations). All data were centrally evaluated by a blinded interpreter. SOPs were then used across four centers to examine the effect of cold storage on CFTR currents and compare CFTR currents in biopsies from one subject studied simultaneously either at two sites (24 hours post-biopsy) or when biopsies were obtained by either forceps or suction. Rectal biopsies from 44 non-CF and 17 CF subjects were analyzed. Mean differences (µA/cm(2); 95% confidence intervals) between CF and non-CF were forskolin/IBMX=102.6(128.0 to 81.1), carbachol=96.3(118.7 to 73.9), forskolin/IBMX+carbachol=200.9(243.1 to 158.6), and bumetanide=-44.6 (-33.7 to -55.6) (P<0.005, CF vs non-CF for all parameters). Receiver Operating Characteristic curves indicated that each parameter discriminated CF from non-CF subjects (area under the curve of 0.94-0.98). CFTR dependent currents following 18-24 hours of cold storage for forskolin/IBMX, carbachol, and forskolin/IBMX+carbachol stimulation (n=17 non-CF subjects) were 44%, 47.5%, and 47.3%, respectively of those in fresh biopsies. CFTR-dependent currents from biopsies studied after cold storage at two sites simultaneously demonstrated moderate correlation (n=14 non-CF subjects, Pearson correlation coefficients 0.389, 0.484, and 0.533). Similar CFTR dependent currents were detected from fresh biopsies obtained by either forceps or suction (within-subject comparisons, n=22 biopsies from three non-CF subjects). Multicenter ICM is a feasible CFTR outcome measure that discriminates CF from non-CF ion transport, offers unique advantages over other CFTR bioassays, and warrants further development as a potential CFTR biomarker.http://europepmc.org/articles/PMC3769519?pdf=render |
spellingShingle | John P Clancy Rhonda D Szczesniak Melissa A Ashlock Sarah E Ernst Lijuan Fan Douglas B Hornick Philip H Karp Umer Khan James Lymp Alicia J Ostmann Amir Rezayat Timothy D Starner Shajan P Sugandha Hongtao Sun Nancy Quinney Scott H Donaldson Steven M Rowe Sherif E Gabriel Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function. PLoS ONE |
title | Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function. |
title_full | Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function. |
title_fullStr | Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function. |
title_full_unstemmed | Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function. |
title_short | Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function. |
title_sort | multicenter intestinal current measurements in rectal biopsies from cf and non cf subjects to monitor cftr function |
url | http://europepmc.org/articles/PMC3769519?pdf=render |
work_keys_str_mv | AT johnpclancy multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT rhondadszczesniak multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT melissaaashlock multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT saraheernst multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT lijuanfan multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT douglasbhornick multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT philiphkarp multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT umerkhan multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT jameslymp multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT aliciajostmann multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT amirrezayat multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT timothydstarner multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT shajanpsugandha multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT hongtaosun multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT nancyquinney multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT scotthdonaldson multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT stevenmrowe multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction AT sherifegabriel multicenterintestinalcurrentmeasurementsinrectalbiopsiesfromcfandnoncfsubjectstomonitorcftrfunction |